Campbell & Co Investment Adviser’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
18,960
-72,604
-79% -$1.14M 0.02% 878
2026
Q1
$1.31M Buy
91,564
+53,905
+143% +$895K 0.07% 417
2025
Q4
$664K Sell
37,659
-24,723
-40% -$409K 0.03% 720
2025
Q3
$981K Sell
62,382
-33,128
-35% -$465K 0.07% 429
2025
Q2
$1.06M Sell
95,510
-18,740
-16% -$219K 0.07% 477
2025
Q1
$1.33M Buy
114,250
+20,142
+21% +$259K 0.1% 315
2024
Q4
$1.29M Buy
94,108
+19,824
+27% +$287K 0.1% 300
2024
Q3
$1.24M Buy
74,284
+38,663
+109% +$565K 0.09% 356
2024
Q2
$423K Buy
35,621
+21,020
+144% +$240K 0.04% 710
2024
Q1
$175K Sell
14,601
-2,596
-15% -$38.6K 0.02% 1027
2023
Q4
$290K Sell
17,197
-11,667
-40% -$165K 0.03% 930
2023
Q3
$432K Buy
+28,864
New +$487K 0.05% 582

Other funds holding SHC

Campbell & Co Investment Adviser's SHC Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Sotera Health (SHC) stake by 79% in Q2 2026, selling an estimated $1.14M and leaving 18,960 shares worth $337K. The position accounts for 0.02% of the portfolio, ranked #878.

Campbell & Co Investment Adviser first reported a position in SHC in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.33M in Q1 2025. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Campbell & Co Investment Adviser held 18,960 shares of Sotera Health worth $337K as of Q2 2026.
  • Campbell & Co Investment Adviser sold 72,604 Sotera Health shares in Q2 2026, an estimated $1.14M.
  • Sotera Health made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #878 holding.
  • Campbell & Co Investment Adviser first reported a position in Sotera Health in Q3 2023 and has held it in 12 quarters since.
  • Campbell & Co Investment Adviser's Sotera Health position peaked at $1.33M in Q1 2025.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.